Literature DB >> 23839158

Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.

Evangelos Voudoukis1, Konstantinos Karmiris, Pantelis Oustamanolakis, Angeliki Theodoropoulou, Aekaterini Sfiridaki, Gregorios A Paspatis, Ioannis E Koutroubakis.   

Abstract

BACKGROUND: Thrombocytosis and iron deficiency anemia are frequent complications of inflammatory bowel disease (IBD). The aim of this study was to investigate the correlation between iron deficiency anemia and thrombocytosis in IBD patients.
METHODS: A total of 198 consecutive IBD patients and 102 healthy controls participated in the study. The parameters investigated were: platelets (PLT), mean platelet volume, platelet distribution width, plateletcrit, hematocrit (HCT) levels, hemoglobulin (Hb) levels, mean corpuscular volume (MCV), red cell distribution width (RDW), ferritin levels, soluble transferrin receptor (sTfR) levels, the sTfR-F index (sTfR-F=sTfR/log10 ferritin), and vitamin B12 and folate levels. Thrombocytosis was defined as an absolute number of PLT greater than 400k/μl. Disease activity indices (Crohn's Disease Activity Index for Crohn's disease and Simple Clinical Colitis Activity Index for ulcerative colitis) as well as C-reactive protein (CRP) were also correlated with the study parameters.
RESULTS: The IBD patients demonstrated decreased HCT levels, Hb levels, MCV, mean platelet volume, and ferritin levels and an increased absolute PLT count, RDW, platelet distribution width, plateletcrit, sTfR and sTfR-F index (P<0.0001) compared with healthy controls. Twenty-seven patients exhibited thrombocytosis (13.6%). The median value for PLT (interquartile range) was 289 (228-355)k/μl, for Hb levels was 13.4 (12.0-14.7) g/dl, for ferritin levels was 36.6 (19.7-80.7) ng/ml, and for sTfR-F was 0.82 (0.61-1.37) mg/l. The PLT in IBD patients correlated with HCT levels, Hb levels, MCV, RDW, Fe levels, ferritin levels, sTfR, sTfR-F, CRP levels, Simple Clinical Colitis Activity Index, and Crohn's Disease Activity Index (Spearman's ρ correlation). In the multivariate analysis, only Hb levels, RDW, CRP levels, ferritin levels, and sTfR-F remained significant (P<0.05). None of the aforementioned was observed in the control group.
CONCLUSION: The absolute PLT count seems to correlate with iron deficiency anemia parameters and disease activity in IBD patients. Controlling the inflammation and managing iron deficiency could lead to reversal of thrombocytosis in IBD patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23839158     DOI: 10.1097/MEG.0b013e328363e354

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  16 in total

1.  Persistent Reactive Thrombocytosis May Increase the Risk of Coronary Artery Disease Among Inflammatory Bowel Disease Patients.

Authors:  Sudeep Dhoj Thapa; Hiba Hadid; Waseem Imam; Ahmad Hassan; Muhammad Usman; Syed-Mohammed Jafri; Jason Schairer
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

Review 2.  Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide.

Authors:  Fernando Gomollón; Javier P Gisbert
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 3.  Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.

Authors:  Evangelos Voudoukis; Konstantinos Karmiris; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

4.  Telephone Encounters Predict Future High Financial Expenditures in Inflammatory Bowel Disease Patients: A 3-Year Prospective Observational Study.

Authors:  Benjamin Click; Alyce M Anderson; Claudia Ramos Rivers; Ioannis E Koutroubakis; Jana G Hashash; Michael A Dunn; Marc Schwartz; Jason Swoger; Arthur Barrie; Eva Szigethy; Miguel Regueiro; Robert E Schoen; David G Binion
Journal:  J Clin Gastroenterol       Date:  2018-04       Impact factor: 3.062

5.  Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.

Authors:  Michał Łodyga; Piotr Eder; Magdalena Gawron-Kiszka; Agnieszka Dobrowolska; Maciej Gonciarz; Marek Hartleb; Maria Kłopocka; Ewa Małecka-Wojciesko; Piotr Radwan; Jarosław Reguła; Edyta Zagórowicz; Grażyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2021-11-19

6.  Management of Iron Deficiency Anemia.

Authors:  Kristine Jimenez; Stefanie Kulnigg-Dabsch; Christoph Gasche
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-04

Review 7.  [Iron deficiency, thrombocytosis and thromboembolism].

Authors:  Rayko Evstatiev
Journal:  Wien Med Wochenschr       Date:  2016-09-28

8.  ACG Clinical Guideline: Management of Crohn's Disease in Adults.

Authors:  Gary R Lichtenstein; Edward V Loftus; Kim L Isaacs; Miguel D Regueiro; Lauren B Gerson; Bruce E Sands
Journal:  Am J Gastroenterol       Date:  2018-03-27       Impact factor: 10.864

9.  First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.

Authors:  Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

10.  Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin.

Authors:  Rayko Evstatiev; Adam Bukaty; Kristine Jimenez; Stefanie Kulnigg-Dabsch; Lidia Surman; Werner Schmid; Robert Eferl; Kathrin Lippert; Barbara Scheiber-Mojdehkar; Hans Michael Kvasnicka; Vineeta Khare; Christoph Gasche
Journal:  Am J Hematol       Date:  2014-02-24       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.